WE@HealthTech
Nora Nseir is a highly experienced professional in the biomedical engineering field, currently serving as Co-CEO and inventor at Nurami Medical, a pioneering medical device company specializing in nanofiber technology for soft tissue repair. Nseir's leadership at Nurami has helped secure $10 million in funding, targeting a substantial global market. Previously, Nseir held significant roles at Technion, including Development Project Leader and R&D Engineer, contributing to the development of innovative surgical solutions. Alongside involvement in health technology organizations like WE@HealthTech and 8400 The Health Network, Nseir has an academic background with a Master's and Bachelor's degree in Biomedical/Medical Engineering from Technion.
This person is not in the org chart
WE@HealthTech
Women comprise about 70% of the HealthTech industry work force. Out of the 30 companies listed in the Biomed Index there are only two women CEOs amongst a total of sixty CEOs and Chairmen. The share value of companies that include women on their boards are higher by an average of 44% (Goldman Sachs). FORTUNE 500 companies with a larger number of women in senior management positions have better financial results (Catalyst). It follows that proper representation of women in top managerial levels will serve not only social and gender equality goals, but also organizational, business, and economic goals and performance. In partnership with 8400 we introduce a HealthTech launchpad program to promote junior women managers to executive positions throughout the ecosystem.